1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA HCFC2 CTRPv2 pan-cancer AAC -0.17 1e-05
mRNA VAMP8 CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA RASGRP2 CTRPv2 pan-cancer AAC 0.19 1e-05
mRNA NIPA1 CTRPv2 pan-cancer AAC -0.15 1e-05
mRNA PPP1R36 CTRPv2 pan-cancer AAC 0.16 1e-05
mRNA DUSP4 CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA BROX CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA METTL16 CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA SGTB CTRPv2 pan-cancer AAC -0.16 1e-05
mRNA PSD4 CTRPv2 pan-cancer AAC 0.19 1e-05
Download CSV